Literature DB >> 6691102

Magnetic resonance imaging of the thorax in childhood. Work in progress.

R C Brasch, C A Gooding, D P Lallemand, G E Wesbey.   

Abstract

Magnetic resonance (MR) imaging was performed in 10 children with intrathoracic disease. Entities imaged included mediastinal lymphoma and neuroblastoma, pulmonary metastases from hepatoblastoma and osteogenic sarcoma, hemorrhagic pleural effusion, and nonmalignant disease such as abscess, cystic fibrosis, and bronchogenic cyst. MR imaging was particularly valuable in delineating mediastinal and parenchymal masses from adjacent vascular structures without the need for contrast material enhancement. However, MR was insensitive to lesion calcification. Since pulmonary vessels give very low signal, differentiation of high-intensity pulmonary nodules from vessels is readily apparent. For similar reasons, MR was excellent in distinguishing endobronchial mucus plugs from peripheral pulmonary vessels.

Entities:  

Mesh:

Year:  1984        PMID: 6691102     DOI: 10.1148/radiology.150.2.6691102

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Magnetic resonance of the pulmonary parenchyma: initial experience at 0.6 Tesla.

Authors:  P B O'Donovan; J S Ross
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

2.  MRI appearance of esophageal duplication cyst.

Authors:  A R Lupetin; N Dash
Journal:  Gastrointest Radiol       Date:  1987

3.  Imaging for anaesthetists: a review of the methods and anaesthetic implications of diagnostic imaging techniques.

Authors:  G Weston; L Strunin; G M Amundson
Journal:  Can Anaesth Soc J       Date:  1985-09

4.  MRI in tracheal stenosis by innominate artery in children.

Authors:  T Vogl; C Wilimzig; U Hofmann; D Hofmann; S Dresel; J Lissner
Journal:  Pediatr Radiol       Date:  1991

Review 5.  [Thoracic findings in pediatric patients with cystic fibrosis].

Authors:  R Wunsch; C Wunsch
Journal:  Radiologe       Date:  2003-12       Impact factor: 0.635

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.